Cargando…
398. Increased Risk of Severe COVID-19 Outcomes Across all Groups of Individuals with Hematological Malignancies, Solid Tumors, and Solid Organ Transplants Compared with the General Population: Initial Results from INFORM, a Retrospective Health Database Observational Study in England
BACKGROUND: Despite COVID-19 vaccination, individuals who are immunocompromised due to underlying conditions, such as cancer and organ transplant, are at a greater risk of severe COVID-19 outcomes compared with the general population that is vaccinated. However, there are limited data quantifying th...
Autores principales: | McNulty, Richard, Dube, Sabada, Lu, Yi, Graham, Sophie, Arnetorp, Sofie, Justo, Nahila, Yokota, Renata, Evans, Kathryn, Venkatesan, Sudhir, Yates, Mark, Taylor, Sylvia, Quint, Jennifer, Evans, Rachael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679405/ http://dx.doi.org/10.1093/ofid/ofad500.468 |
Ejemplares similares
-
1095. Increased Risk of COVID-19 Hospitalization and Death in Vaccinated Patients with End-Stage Renal Disease (ESRD) and Dialysis: Initial Results from INFORM, a Retrospective Health Database Observational Study in England
por: Dube, Sabada, et al.
Publicado: (2023) -
1096. Fully Vaccinated Individuals with Immunocompromised Conditions (IC) are Still at Increased Risk of Severe COVID-19 Outcomes From the Omicron Variant: Initial Results From INFORM, a Retrospective Health Database Observational Study in England
por: Dube, Sabada, et al.
Publicado: (2023) -
Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009) -
Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy
por: Cui, Yuehong, et al.
Publicado: (2012) -
Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors
por: Federico, Mario, et al.
Publicado: (2011)